$75.99
+11.19 (+17.27%)
Performance
1D
+0.00%
1W
+22.64%
1M
+20.12%
3M
-0.74%
6M
+9.62%
1Y
+91.51%
YTD
+81.84%
Open$66.49
Previous Close$64.80
Day High$80.03
Day Low$66.17
52W High$80.97
52W Low$35.80
Volume—
Avg Volume923.0K
Market Cap5.74B
P/E Ratio—
EPS$-2.70
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$68.24
Above
SMA 200
$66.20
Above
RSI (14)
76.5
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-52.7% upside
Current
$75.99
$75.99
Target
$35.94
$35.94
$23.54
$35.94 avg
$41.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.95M | 3.43M | 1.61B |
| Net Income | -157,418,578 | -239,151,834 | -285,460,132 |
| Profit Margin | -3,985.0% | -7,343.0% | -17.7% |
| EBITDA | -185,128,965 | -328,687,347 | -344,556,820 |
| Free Cash Flow | — | — | -296,727,069 |
| Rev Growth | +176.6% | -52.1% | +15.2% |
| Debt/Equity | 0.00 | — | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |